Market Overview:
The global live cell RNA detection market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The market growth is attributed to the increasing demand for live cell RNA detection products in the biotechnology companies, academic institutes, and others sectors. Additionally, the growing application of live cell RNA detection products in drug discovery and development is also fueling the growth of this market. However, high cost associated with these products may restrain the growth of this market during the forecast period. On basis of type, linear oligonucleotide probe segment accounted for major share in global live cell RNA detection market in 2017 and it is projected to maintain its dominance during forecast period as well. This can be attributed to its low cost as compared to other types such as molecular beacon and MS2-GFP segments.
Product Definition:
Live cell RNA detection is a technique that is used to detect RNA in live cells. This technique can be used to determine the expression of specific genes or proteins in live cells. The importance of this technique is that it can be used to study the function of specific genes or proteins in live cells.
Linear Oligonucleotide Probe:
Linear oligonucleotide probes (LNP) are synthetic, non-natural nucleotides that are capable of hybridizing with DNA or RNA. They can be used as a tool for the detection and purification of target sequences in both single-stranded and double-stranded DNA/RNA. The ability to detect gene expression using LNP has been an ongoing area of research interest for several years.
Linear FRET Probe:
Linear FRET probe is a new type of genetic probe that works in a manner similar to the conventional fluorescent dyes. It consists of two complementary oligonucleotides, which are linked by a linker and attached to an affinity tag. The other end of the oligonucleotide is labeled with an enzyme binding domain. Linear FRET probes are synthesized as long synthetic oligos containing perfect matchstick sequences, which enable them to bind specifically along their length.
Application Insights:
The others application segment held the largest share of over 50.0% in 2017. The other applications include research institutes, biotechnology companies and diagnostic laboratories among others. Biotechnology companies are at the forefront of this industry as they have a deep pipeline of product candidates for various clinical trials and are thus expected to be one of the fastest-growing segments during the forecast period.
Linear FRET probes are used extensively in drug development for cancer diagnostics, biomarker discovery and cell line screening due to its ability to simultaneously detect fluorescence resonance energy transfer (FRET) between two fluorophores that occur when a DNA probe hybridizes with an RNA target molecule, which provides strong signal amplification resulting in high detection efficiency compared to other technologies such as MS2-GFP or molecular beacons (MB). This is also likely to boost market growth during the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This is due to presence of a large number of biotechnology companies and significant funding for R&D in this region. Moreover, increasing prevalence of cancer and other diseases has led to increased adoption of these technologies across this region. For instance, according to the American Cancer Society, Inc., around 2 million new cases were estimated to be diagnosed in U.
Growth Factors:
- Increasing demand for early diagnosis of diseases: The increasing demand for early diagnosis of diseases is one of the key growth drivers for the live cell RNA detection market. This is because early diagnosis can help in better treatment outcomes and also helps in reducing the overall cost of treatment.
- Rising prevalence of chronic diseases: The rising prevalence of chronic diseases, such as cancer, diabetes, and heart disease is another major factor that is driving the growth of the live cell RNA detection market. This is because these diseases are often associated with high rates of morbidity and mortality.
- Technological advancements in life science research: The technological advancements in life science research are another key factor that is driving the growth of the live cell RNA detection market. This is because these advancements are helping researchers to detect minute amounts or even single moleculesof RNA present in a living cell sample with great accuracy and precision..
Scope Of The Report
Report Attributes
Report Details
Report Title
Live Cell RNA Detection Market Research Report
By Type
Linear Oligonucleotide Probe, Linear FRET Probe, Autoligation FRET Probe, Molecular Beacon, MS2-GFP, Others
By Application
Biotechnology Companies, Academic Institutes, Others
By Companies
Merck, BioTek Instruments, Thermo Fisher Scientific, Agilent Technologies, Promega, Biomol, Advanced Cell Diagnostics, Qiagen Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Live Cell RNA Detection Market Report Segments:
The global Live Cell RNA Detection market is segmented on the basis of:
Types
Linear Oligonucleotide Probe, Linear FRET Probe, Autoligation FRET Probe, Molecular Beacon, MS2-GFP, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biotechnology Companies, Academic Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- BioTek Instruments
- Thermo Fisher Scientific
- Agilent Technologies
- Promega
- Biomol
- Advanced Cell Diagnostics
- Qiagen Diagnostics
Highlights of The Live Cell RNA Detection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Linear Oligonucleotide Probe
- Linear FRET Probe
- Autoligation FRET Probe
- Molecular Beacon
- MS2-GFP
- Others
- By Application:
- Biotechnology Companies
- Academic Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Live Cell RNA Detection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Live Cell RNA Detection is a process that uses real-time PCR to detect the presence of RNA in cells. This technology can be used to identify different types of cancer, as well as other diseases and abnormalities.
Some of the key players operating in the live cell rna detection market are Merck, BioTek Instruments, Thermo Fisher Scientific, Agilent Technologies, Promega, Biomol, Advanced Cell Diagnostics, Qiagen Diagnostics.
The live cell rna detection market is expected to register a CAGR of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Live Cell RNA Detection Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Live Cell RNA Detection Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Live Cell RNA Detection Market - Supply Chain
4.5. Global Live Cell RNA Detection Market Forecast
4.5.1. Live Cell RNA Detection Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Live Cell RNA Detection Market Size (000 Units) and Y-o-Y Growth
4.5.3. Live Cell RNA Detection Market Absolute $ Opportunity
5. Global Live Cell RNA Detection Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Live Cell RNA Detection Market Size and Volume Forecast by Type
5.3.1. Linear Oligonucleotide Probe
5.3.2. Linear FRET Probe
5.3.3. Autoligation FRET Probe
5.3.4. Molecular Beacon
5.3.5. MS2-GFP
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Live Cell RNA Detection Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Live Cell RNA Detection Market Size and Volume Forecast by Application
6.3.1. Biotechnology Companies
6.3.2. Academic Institutes
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Live Cell RNA Detection Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Live Cell RNA Detection Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Live Cell RNA Detection Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Live Cell RNA Detection Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Live Cell RNA Detection Demand Share Forecast, 2019-2029
9. North America Live Cell RNA Detection Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Live Cell RNA Detection Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Live Cell RNA Detection Market Size and Volume Forecast by Application
9.4.1. Biotechnology Companies
9.4.2. Academic Institutes
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Live Cell RNA Detection Market Size and Volume Forecast by Type
9.7.1. Linear Oligonucleotide Probe
9.7.2. Linear FRET Probe
9.7.3. Autoligation FRET Probe
9.7.4. Molecular Beacon
9.7.5. MS2-GFP
9.7.6. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Live Cell RNA Detection Demand Share Forecast, 2019-2029
10. Latin America Live Cell RNA Detection Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Live Cell RNA Detection Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Live Cell RNA Detection Market Size and Volume Forecast by Application
10.4.1. Biotechnology Companies
10.4.2. Academic Institutes
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Live Cell RNA Detection Market Size and Volume Forecast by Type
10.7.1. Linear Oligonucleotide Probe
10.7.2. Linear FRET Probe
10.7.3. Autoligation FRET Probe
10.7.4. Molecular Beacon
10.7.5. MS2-GFP
10.7.6. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Live Cell RNA Detection Demand Share Forecast, 2019-2029
11. Europe Live Cell RNA Detection Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Live Cell RNA Detection Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Live Cell RNA Detection Market Size and Volume Forecast by Application
11.4.1. Biotechnology Companies
11.4.2. Academic Institutes
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Live Cell RNA Detection Market Size and Volume Forecast by Type
11.7.1. Linear Oligonucleotide Probe
11.7.2. Linear FRET Probe
11.7.3. Autoligation FRET Probe
11.7.4. Molecular Bacon
11.7.5. MS2-GFP
11.7.6. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Live Cell RNA Detection Demand Share, 2019-2029
12. Asia Pacific Live Cell RNA Detection Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Live Cell RNA Detection Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Live Cell RNA Detection Market Size and Volume Forecast by Application
12.4.1. Biotechnology Companies
12.4.2. Academic Institutes
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Live Cell RNA Detection Market Size and Volume Forecast by Type
12.7.1. Linear Oligonucleotide Probe
12.7.2. Linear FRET Probe
12.7.3. Autoligation FRET Probe
12.7.4. Molecular Beacon
12.7.5. MS2-GFP
12.7.6. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Live Cell RNA Detection Demand Share, 2019-2029
13. Middle East & Africa Live Cell RNA Detection Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Live Cell RNA Detection Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Live Cell RNA Detection Market Size and Volume Forecast by Application
13.4.1. Biotechnology Companies
13.4.2. Academic Institutes
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Live Cell RNA Detection Market Size and Volume Forecast by Type
13.7.1. Linear Oligonucleotide Probe
13.7.2. Linear FRET Probe
13.7.3. Autoligation FRET Probe
13.7.4. Molecular Beacon
13.7.5. MS2-GFP
13.7.6. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Live Cell RNA Detection Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Live Cell RNA Detection Market: Market Share Analysis
14.2. Live Cell RNA Detection Distributors and Customers
14.3. Live Cell RNA Detection Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Merck
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. BioTek Instruments
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Thermo Fisher Scientific
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Agilent Technologies
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Promega
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Biomol
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Advanced Cell Diagnostics
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Qiagen Diagnostics
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
